U.S. flag

An official website of the United States government

Format
Items per page
Sort by
Choose Destination

Links from MedGen

Items: 1 to 100 of 351

VariationLocationGene(s)Protein changeCondition(s)Clinical significance
(Last reviewed)
Review status
1.
GRCh37:
Chr2:241813394
GRCh38:
Chr2:240873977
AGXTPrimary hyperoxaluria, type IPathogeniccriteria provided, single submitter
2.
GRCh37:
Chr2:241817041
GRCh38:
Chr2:240877624
AGXTK190*, K312*Primary hyperoxaluria, type ILikely pathogenic
(Jan 2, 2022)
criteria provided, single submitter
3.
GRCh37:
Chr2:241808679
GRCh38:
Chr2:240869262
AGXTE87fsPrimary hyperoxaluria, type ILikely pathogenic
(Dec 12, 2021)
criteria provided, single submitter
4.
GRCh37:
Chr2:241814551
GRCh38:
Chr2:240875134
AGXTK236*Primary hyperoxaluria, type ILikely pathogenic
(Mar 31, 2022)
criteria provided, single submitter
5.
GRCh37:
Chr2:241808700
GRCh38:
Chr2:240869283
AGXTL94fsPrimary hyperoxaluria, type ILikely pathogenic
(Mar 30, 2022)
criteria provided, single submitter
6.
GRCh37:
Chr2:241808657-241808669
GRCh38:
Chr2:240869240-240869252
AGXTG80fsPrimary hyperoxaluria, type ILikely pathogenic
(Mar 29, 2022)
criteria provided, single submitter
7.
GRCh37:
Chr2:241812407
GRCh38:
Chr2:240872990
AGXTL179fsPrimary hyperoxaluria, type ILikely pathogenic
(Mar 14, 2022)
criteria provided, single submitter
8.
GRCh37:
Chr2:241812399
GRCh38:
Chr2:240872982
AGXTY176*Primary hyperoxaluria, type ILikely pathogenic
(Mar 8, 2022)
criteria provided, single submitter
9.
GRCh37:
Chr2:241812449-241812450
GRCh38:
Chr2:240873032-240873033
AGXTY194fsPrimary hyperoxaluria, type ILikely pathogenic
(Mar 5, 2022)
criteria provided, single submitter
10.
GRCh37:
Chr2:241808313-241808314
GRCh38:
Chr2:240868896-240868897
AGXTP11fsPrimary hyperoxaluria, type ILikely pathogenic
(Mar 25, 2022)
criteria provided, single submitter
11.
GRCh37:
Chr2:241810137
GRCh38:
Chr2:240870720
AGXTnot provided, Primary hyperoxaluria, type ILikely benign
(May 23, 2022)
criteria provided, multiple submitters, no conflicts
12.
GRCh37:
Chr2:241810825
GRCh38:
Chr2:240871408
AGXTnot provided, Primary hyperoxaluria, type ILikely benign
(Oct 25, 2022)
criteria provided, multiple submitters, no conflicts
13.
GRCh37:
Chr2:241817561
GRCh38:
Chr2:240878144
AGXTnot provided, Primary hyperoxaluria, type IConflicting interpretations of pathogenicity
(Sep 27, 2022)
criteria provided, conflicting interpretations
14.
GRCh37:
Chr2:241817498
GRCh38:
Chr2:240878081
AGXTnot provided, Primary hyperoxaluria, type ILikely benign
(Sep 13, 2022)
criteria provided, multiple submitters, no conflicts
15.
GRCh37:
Chr2:241813441
GRCh38:
Chr2:240874024
AGXTP215fsPrimary hyperoxaluria, type IPathogenic
(Aug 19, 2021)
criteria provided, single submitter
16.
GRCh37:
Chr2:241815413
GRCh38:
Chr2:240875996
AGXTA280fsPrimary hyperoxaluria, type ILikely pathogenic
(Oct 11, 2021)
criteria provided, single submitter
17.
GRCh37:
Chr2:241808726
GRCh38:
Chr2:240869309
AGXTV102DPrimary hyperoxaluria, type ILikely pathogenic
(Oct 12, 2021)
criteria provided, single submitter
18.
GRCh37:
Chr2:241817176
GRCh38:
Chr2:240877759
AGXTnot provided, Primary hyperoxaluria, type IBenign
(Jul 10, 2021)
criteria provided, multiple submitters, no conflicts
19.
GRCh37:
Chr2:241816871
GRCh38:
Chr2:240877454
AGXTnot provided, Primary hyperoxaluria, type IBenign
(Jul 10, 2021)
criteria provided, multiple submitters, no conflicts
20.
GRCh37:
Chr2:241815620
GRCh38:
Chr2:240876203
AGXTnot provided, Primary hyperoxaluria, type IBenign
(Jul 10, 2021)
criteria provided, multiple submitters, no conflicts
21.
GRCh37:
Chr2:241815591
GRCh38:
Chr2:240876174
AGXTnot provided, Primary hyperoxaluria, type IBenign
(Jul 10, 2021)
criteria provided, multiple submitters, no conflicts
22.
GRCh37:
Chr2:241812566
GRCh38:
Chr2:240873149
AGXTPrimary hyperoxaluria, type I, not providedBenign
(Jul 10, 2021)
criteria provided, multiple submitters, no conflicts
23.
GRCh37:
Chr2:241808942
GRCh38:
Chr2:240869525
AGXTPrimary hyperoxaluria, type I, not providedBenign
(Jul 10, 2021)
criteria provided, multiple submitters, no conflicts
24.
GRCh37:
Chr2:241813459
GRCh38:
Chr2:240874042
AGXTPrimary hyperoxaluria, type I, not providedLikely benign
(Oct 31, 2022)
criteria provided, multiple submitters, no conflicts
25.
GRCh37:
Chr2:241810792
GRCh38:
Chr2:240871375
AGXTnot providedLikely benign
(Feb 21, 2022)
criteria provided, single submitter
26.
GRCh37:
Chr2:241808309
GRCh38:
Chr2:240868892
AGXTnot provided, Primary hyperoxaluria, type ILikely benign
(Sep 16, 2022)
criteria provided, multiple submitters, no conflicts
27.
GRCh37:
Chr2:241818229
GRCh38:
Chr2:240878812
AGXTnot providedLikely benign
(Oct 30, 2022)
criteria provided, single submitter
28.
GRCh37:
Chr2:241813385
GRCh38:
Chr2:240873968
AGXTnot provided, Primary hyperoxaluria, type ILikely benign
(Jan 18, 2022)
criteria provided, multiple submitters, no conflicts
29.
GRCh37:
Chr2:241813388
GRCh38:
Chr2:240873971
AGXTPrimary hyperoxaluria, type I, not providedLikely benign
(Oct 15, 2022)
criteria provided, multiple submitters, no conflicts
30.
GRCh37:
Chr2:241817477
GRCh38:
Chr2:240878060
AGXTnot provided, Primary hyperoxaluria, type ILikely benign
(May 26, 2022)
criteria provided, multiple submitters, no conflicts
31.
GRCh37:
Chr2:241813436
GRCh38:
Chr2:240874019
AGXTA213Tnot provided, Primary hyperoxaluria, type IUncertain significance
(Jan 27, 2022)
criteria provided, multiple submitters, no conflicts
32.
GRCh37:
Chr2:241816989
GRCh38:
Chr2:240877572
AGXTnot providedLikely benign
(Oct 3, 2022)
criteria provided, single submitter
33.
GRCh37:
Chr2:241815426
GRCh38:
Chr2:240876009
AGXTPrimary hyperoxaluria, type IUncertain significance
(Feb 23, 2022)
criteria provided, single submitter
34.
GRCh37:
Chr2:241812422
GRCh38:
Chr2:240873005
AGXTS184LPrimary hyperoxaluria, type IUncertain significance
(Jan 8, 2022)
criteria provided, single submitter
35.
GRCh37:
Chr2:241808762
GRCh38:
Chr2:240869345
AGXTD114GPrimary hyperoxaluria, type IUncertain significance
(Aug 14, 2020)
no assertion criteria provided
36.
GRCh37:
Chr2:241813452
GRCh38:
Chr2:240874035
AGXTS218*Primary hyperoxaluria, type ILikely pathogenic
(Feb 2, 2020)
criteria provided, single submitter
37.
GRCh37:
Chr2:241810781
GRCh38:
Chr2:240871364
AGXTK147*Primary hyperoxaluria, type ILikely pathogenic
(Dec 22, 2019)
criteria provided, single submitter
38.
GRCh37:
Chr2:241810114
GRCh38:
Chr2:240870697
AGXTE138*Primary hyperoxaluria, type ILikely pathogenic
(Oct 18, 2019)
criteria provided, single submitter
39.
GRCh37:
Chr2:241808779
GRCh38:
Chr2:240869362
AGXTG120*Primary hyperoxaluria, type ILikely pathogenic
(Dec 16, 2019)
criteria provided, single submitter
40.
GRCh37:
Chr2:241808673
GRCh38:
Chr2:240869256
AGXTC84*Primary hyperoxaluria, type ILikely pathogenic
(May 31, 2019)
criteria provided, single submitter
41.
GRCh37:
Chr2:241808619
GRCh38:
Chr2:240869202
AGXTY66*Primary hyperoxaluria, type IPathogenic/Likely pathogenic
(Nov 12, 2021)
criteria provided, multiple submitters, no conflicts
42.
GRCh37:
Chr2:241812405
GRCh38:
Chr2:240872988
AGXTC178WPrimary hyperoxaluria, type ILikely pathogenic
(Jul 2, 2020)
criteria provided, single submitter
43.
GRCh37:
Chr2:241810073-241810080
GRCh38:
Chr2:240870656-240870663
AGXTP125fsPrimary hyperoxaluria, type I, not providedPathogenic/Likely pathogenic
(Dec 8, 2021)
criteria provided, multiple submitters, no conflicts
44.
GRCh37:
Chr2:241808707
GRCh38:
Chr2:240869290
AGXTP96Anot provided, Primary hyperoxaluria, type IUncertain significance
(Mar 7, 2022)
criteria provided, multiple submitters, no conflicts
45.
GRCh37:
Chr2:241808779
GRCh38:
Chr2:240869362
AGXTG120Rnot provided, Primary hyperoxaluria, type IUncertain significance
(Mar 22, 2022)
criteria provided, multiple submitters, no conflicts
46.
GRCh37:
Chr2:241808352
GRCh38:
Chr2:240868935
AGXTL24IPrimary hyperoxaluria, type I, not providedUncertain significance
(Nov 13, 2021)
criteria provided, multiple submitters, no conflicts
47.
GRCh37:
Chr2:241817468
GRCh38:
Chr2:240878051
AGXTA325fsnot provided, Primary hyperoxaluria, type IPathogenic/Likely pathogenic
(Aug 30, 2022)
criteria provided, multiple submitters, no conflicts
48.
GRCh37:
Chr2:241808593
GRCh38:
Chr2:240869176
AGXTD58Nnot providedUncertain significance
(Sep 1, 2021)
criteria provided, single submitter
49.
GRCh37:
Chr2:241810852
GRCh38:
Chr2:240871435
AGXTPrimary hyperoxaluria, type I, not providedConflicting interpretations of pathogenicity
(Sep 25, 2022)
criteria provided, conflicting interpretations
50.
GRCh37:
Chr2:241818523
GRCh38:
Chr2:240879106
AGXTPrimary hyperoxaluria, type IUncertain significance
(Jan 13, 2018)
criteria provided, single submitter
51.
GRCh37:
Chr2:241818432
GRCh38:
Chr2:240879015
AGXTPrimary hyperoxaluria, type IUncertain significance
(Jan 12, 2018)
criteria provided, single submitter
52.
GRCh37:
Chr2:241818290
GRCh38:
Chr2:240878873
AGXTPrimary hyperoxaluria, type IUncertain significance
(Jan 13, 2018)
criteria provided, single submitter
53.
GRCh37:
Chr2:241810833
GRCh38:
Chr2:240871416
AGXTQ164LPrimary hyperoxaluria, type IUncertain significance
(Jan 12, 2018)
criteria provided, single submitter
54.
GRCh37:
Chr2:241808635
GRCh38:
Chr2:240869218
AGXTN72Hnot provided, Primary hyperoxaluria, type IConflicting interpretations of pathogenicity
(Nov 1, 2022)
criteria provided, conflicting interpretations
55.
GRCh37:
Chr2:241808595
GRCh38:
Chr2:240869178
AGXTD58EPrimary hyperoxaluria, type IUncertain significance
(Apr 27, 2017)
criteria provided, single submitter
56.
GRCh37:
Chr2:241817561
GRCh38:
Chr2:240878144
AGXTnot provided, Primary hyperoxaluria, type IConflicting interpretations of pathogenicity
(Oct 10, 2022)
criteria provided, conflicting interpretations
57.
GRCh37:
Chr2:241817542
GRCh38:
Chr2:240878125
AGXTG349DPrimary hyperoxaluria, type IUncertain significance
(Jan 13, 2018)
criteria provided, single submitter
58.
GRCh37:
Chr2:241817515
GRCh38:
Chr2:240878098
AGXTI340TPrimary hyperoxaluria, type IUncertain significance
(Jan 13, 2018)
criteria provided, single submitter
59.
GRCh37:
Chr2:241817446
GRCh38:
Chr2:240878029
AGXTR317QPrimary hyperoxaluria, type IUncertain significance
(Jan 12, 2018)
criteria provided, single submitter
60.
GRCh37:
Chr2:241817061
GRCh38:
Chr2:240877644
AGXTnot provided, Primary hyperoxaluria, type IBenign/Likely benign
(Jul 23, 2022)
criteria provided, multiple submitters, no conflicts
61.
GRCh37:
Chr2:241808322
GRCh38:
Chr2:240868905
AGXTnot provided, Primary hyperoxaluria, type IConflicting interpretations of pathogenicity
(Apr 21, 2022)
criteria provided, conflicting interpretations
62.
GRCh37:
Chr2:241808313
GRCh38:
Chr2:240868896
AGXTP11APrimary hyperoxaluria, type IUncertain significance
(Apr 26, 2022)
criteria provided, multiple submitters, no conflicts
63.
GRCh37:
Chr2:241808259
GRCh38:
Chr2:240868842
AGXTPrimary hyperoxaluria, type ILikely benign
(Apr 27, 2017)
criteria provided, single submitter
64.
GRCh37:
Chr2:241817049
GRCh38:
Chr2:240877632
AGXTnot providedUncertain significance
(May 28, 2022)
criteria provided, single submitter
65.
GRCh37:
Chr2:241814527-241814529
GRCh38:
Chr2:240875110-240875112
AGXTK229delPrimary hyperoxaluria, type ILikely pathogenic
(May 28, 2019)
criteria provided, single submitter
66.
GRCh37:
Chr2:241810077
GRCh38:
Chr2:240870660
AGXTPrimary hyperoxaluria, type I, not providedLikely benign
(Jun 30, 2022)
criteria provided, multiple submitters, no conflicts
67.
GRCh37:
Chr2:241814607
GRCh38:
Chr2:240875190
AGXTnot providedLikely benign
(Oct 7, 2022)
criteria provided, single submitter
68.
GRCh37:
Chr2:241815415
GRCh38:
Chr2:240875998
AGXTnot providedLikely benign
(Oct 8, 2022)
criteria provided, single submitter
69.
GRCh37:
Chr2:241816995
GRCh38:
Chr2:240877578
AGXTnot provided, Primary hyperoxaluria, type ILikely benign
(Aug 6, 2022)
criteria provided, multiple submitters, no conflicts
70.
GRCh37:
Chr2:241816992
GRCh38:
Chr2:240877575
AGXTPrimary hyperoxaluria, type I, not providedConflicting interpretations of pathogenicity
(Oct 7, 2022)
criteria provided, conflicting interpretations
71.
GRCh37:
Chr2:241812408
GRCh38:
Chr2:240872991
AGXTnot provided, Primary hyperoxaluria, type IConflicting interpretations of pathogenicity
(Nov 4, 2022)
criteria provided, conflicting interpretations
72.
GRCh37:
Chr2:241816983
GRCh38:
Chr2:240877566
AGXTnot providedLikely benign
(Oct 1, 2022)
criteria provided, single submitter
73.
GRCh37:
Chr2:241815380
GRCh38:
Chr2:240875963
AGXTnot providedBenign
(Oct 20, 2022)
criteria provided, single submitter
74.
GRCh37:
Chr2:241812438
GRCh38:
Chr2:240873021
AGXTnot provided, Primary hyperoxaluria, type IConflicting interpretations of pathogenicity
(Oct 6, 2022)
criteria provided, conflicting interpretations
75.
GRCh37:
Chr2:241815370
GRCh38:
Chr2:240875953
AGXTnot providedLikely benign
(Sep 28, 2022)
criteria provided, single submitter
76.
GRCh37:
Chr2:241812444
GRCh38:
Chr2:240873027
AGXTnot provided, Primary hyperoxaluria, type IBenign/Likely benign
(Oct 8, 2022)
criteria provided, multiple submitters, no conflicts
77.
GRCh37:
Chr2:241817519
GRCh38:
Chr2:240878102
AGXTD341EPrimary hyperoxaluria, type I, not providedBenign/Likely benign
(Nov 1, 2022)
criteria provided, multiple submitters, no conflicts
78.
GRCh37:
Chr2:241810762
GRCh38:
Chr2:240871345
AGXTPrimary hyperoxaluria, type I, not providedLikely benign
(Nov 1, 2022)
criteria provided, multiple submitters, no conflicts
79.
GRCh37:
Chr2:241817445
GRCh38:
Chr2:240878028
AGXTR317WPrimary hyperoxaluria, type I, not providedConflicting interpretations of pathogenicity
(Jul 13, 2023)
criteria provided, conflicting interpretations
80.
GRCh37:
Chr2:241810126
GRCh38:
Chr2:240870709
AGXTPrimary hyperoxaluria, type ILikely pathogenic
(May 25, 2018)
criteria provided, single submitter
81.
GRCh37:
Chr2:241816952-241816953
GRCh38:
Chr2:240877535-240877536
AGXTPrimary hyperoxaluria, type ILikely pathogenic
(May 24, 2018)
criteria provided, single submitter
82.
GRCh37:
Chr2:241810105-241810106
GRCh38:
Chr2:240870688-240870689
AGXTQ137fsPrimary hyperoxaluria, type IPathogenic
(Mar 21, 2018)
criteria provided, single submitter
83.
GRCh37:
Chr2:241814526-241814527
GRCh38:
Chr2:240875109-240875110
AGXTPrimary hyperoxaluria, type IUncertain significance
(Feb 20, 2018)
criteria provided, single submitter
84.
GRCh37:
Chr2:241815356
GRCh38:
Chr2:240875939
AGXTH261Dnot provided, Primary hyperoxaluria, type IConflicting interpretations of pathogenicity
(Jun 15, 2022)
criteria provided, conflicting interpretations
85.
GRCh37:
Chr2:241808364
GRCh38:
Chr2:240868947
AGXTP28SPrimary hyperoxaluria, type IUncertain significance
(Feb 28, 2022)
criteria provided, multiple submitters, no conflicts
86.
GRCh37:
Chr2:241808402-241808403
GRCh38:
Chr2:240868985-240868986
AGXTL43fsPrimary hyperoxaluria, type ILikely pathogenic
(Oct 16, 2017)
criteria provided, single submitter
87.
GRCh37:
Chr2:241810125
GRCh38:
Chr2:240870708
AGXTE141DPrimary hyperoxaluria, type IUncertain significance
(Aug 16, 2017)
criteria provided, single submitter
88.
GRCh37:
Chr2:241810808
GRCh38:
Chr2:240871391
AGXTG156Rnot provided, Primary hyperoxaluria, type IPathogenic
(Dec 2, 2021)
criteria provided, multiple submitters, no conflicts
89.
GRCh37:
Chr2:241818277
GRCh38:
Chr2:240878860
AGXTPrimary hyperoxaluria, type IUncertain significance
(Apr 24, 2017)
criteria provided, single submitter
90.
GRCh37:
Chr2:241810868
GRCh38:
Chr2:240871451
AGXTPrimary hyperoxaluria, type ILikely pathogenic
(Apr 6, 2017)
criteria provided, single submitter
91.
GRCh37:
Chr2:241808674-241808685
GRCh38:
Chr2:240869257-240869268
AGXTnot provided, Primary hyperoxaluria, type IUncertain significance
(May 15, 2022)
criteria provided, multiple submitters, no conflicts
92.
GRCh37:
Chr2:241814525
GRCh38:
Chr2:240875108
AGXTPrimary hyperoxaluria, type ILikely pathogenic
(Mar 29, 2017)
criteria provided, single submitter
93.
GRCh37:
Chr2:241814623
GRCh38:
Chr2:240875206
AGXTPrimary hyperoxaluria, type ILikely pathogenic
(Feb 27, 2017)
criteria provided, single submitter
94.
GRCh37:
Chr2:241815335
GRCh38:
Chr2:240875918
AGXTnot provided, Primary hyperoxaluria, type ILikely benign
(Sep 17, 2022)
criteria provided, multiple submitters, no conflicts
95.
GRCh37:
Chr2:241808427
GRCh38:
Chr2:240869010
AGXTM49Lnot provided, Primary hyperoxaluria, type I, not specified
Conflicting interpretations of pathogenicity
(Oct 27, 2022)
criteria provided, conflicting interpretations
96.
GRCh37:
Chr2:241813475
GRCh38:
Chr2:240874058
AGXTA226Tnot providedUncertain significance
(Aug 22, 2017)
criteria provided, single submitter
97.
GRCh37:
Chr2:241814588
GRCh38:
Chr2:240875171
AGXTA248Vnot provided, Primary hyperoxaluria, type I, Inborn genetic diseases
Conflicting interpretations of pathogenicity
(Mar 29, 2023)
criteria provided, conflicting interpretations
98.
GRCh37:
Chr2:241808310
GRCh38:
Chr2:240868893
AGXTP10Anot providedUncertain significance
(Feb 13, 2016)
criteria provided, single submitter
99.
GRCh37:
Chr2:241813472-241813475
GRCh38:
Chr2:240874055-240874058
AGXTK225fsPrimary hyperoxaluria, type I, not providedPathogenic/Likely pathogenic
(Apr 9, 2022)
criteria provided, multiple submitters, no conflicts
100.
GRCh37:
Chr2:241818400
GRCh38:
Chr2:240878983
AGXTPrimary hyperoxaluria, type IUncertain significance
(Jan 12, 2018)
criteria provided, single submitter
Format
Items per page
Sort by
Choose Destination